KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of GoodwillAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bausch Health Companies (BHC) Share-based Compensation (2016 - 2025)

Bausch Health Companies (BHC) has disclosed Share-based Compensation for 17 consecutive years, with $84.0 million as the latest value for Q4 2025.

  • Quarterly Share-based Compensation rose 95.35% to $84.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $216.0 million through Dec 2025, up 44.0% year-over-year, with the annual reading at $216.0 million for FY2025, 44.0% up from the prior year.
  • Share-based Compensation hit $84.0 million in Q4 2025 for Bausch Health Companies, up from $43.0 million in the prior quarter.
  • In the past five years, Share-based Compensation ranged from a high of $84.0 million in Q4 2025 to a low of $26.0 million in Q2 2022.
  • Historically, Share-based Compensation has averaged $37.6 million across 5 years, with a median of $33.0 million in 2021.
  • Biggest five-year swings in Share-based Compensation: fell 19.51% in 2024 and later skyrocketed 95.35% in 2025.
  • Year by year, Share-based Compensation stood at $33.0 million in 2021, then rose by 6.06% to $35.0 million in 2022, then dropped by 17.14% to $29.0 million in 2023, then skyrocketed by 48.28% to $43.0 million in 2024, then soared by 95.35% to $84.0 million in 2025.
  • Business Quant data shows Share-based Compensation for BHC at $84.0 million in Q4 2025, $43.0 million in Q3 2025, and $46.0 million in Q2 2025.